Share Name Share Symbol Market Type Share ISIN Share Description
Keras Res LSE:KRS London Ordinary Share GB00B649J414 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 0.325p 0.30p 0.35p 0.325p 0.325p 0.325p 8,504,729.00 07:39:34
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Mining 1.9 -2.1 -0.2 - 5.59

Keras Res Share Discussion Threads

Showing 1326 to 1348 of 1350 messages
Chat Pages: 54  53  52  51  50  49  48  47  46  45  44  43  Older
DateSubjectAuthorDiscuss
27/4/2017
12:05
Perhaps it does not really matter now as you or indeed anyone can buy KRS below the placing price which to me is an open invitation to do so as it is AIMHO & DYOR of course an outstanding buying opportunity!
cpap man
25/4/2017
10:55
Another point is that i believe that SHARD CAPITAL raised all or nearly all the funds
cpap man
25/4/2017
10:40
My broker dealt with the main new broker in London for KRS namely SHARD CAPITAL
cpap man
24/4/2017
18:13
After following up with DR plus reading through all the bumph including the latest KRS presentation i added to my position by well over 100% in the placing.... Exciting times these for KRS shareholders!
cpap man
24/4/2017
16:23
DR is on 120k a year.
the count of monte_cristo
24/4/2017
15:59
Was thinking of buying in here. But won't after seeing this in the RNS 'As previously announced, the Company plans to settle additional outstanding liabilities to certain Directors and members of the management team via the issue of additional Ordinary Shares following the forthcoming General Meeting' Classic AIM share looking after the CEO etc and the LTH losing out. Has happened to me on other shares so know the feeling.
pjt105
24/4/2017
15:41
If indeed there is such a demand for the shares, why is the placing at a significant discount to the current sp? Giving the company away a bit now, along with further dilution for long term shareholders.
the count of monte_cristo
24/4/2017
15:33
Keras Resources plc / Index: AIM / Epic: KRS / Sector: Mining 24 April 2017 Keras Resources plc ("Keras" or "the Company") Placing Raises £530,000 and SVS and Shard appointed as Joint Brokers Keras Resources plc is pleased to announce that it has raised £530,000 (before expenses) from new and existing shareholders through the placing of 151,428,560 ordinary shares of 0.1p each ('Ordinary Shares') at a placing price of 0.35p per Ordinary Share (the 'Placing Shares') and the grant of 75,714,280 warrants to subscribe for new Ordinary Shares (the 'Placing Warrants') (together the 'Placing'). The Placing Warrants are exercisable at price of 0.5p per warrant, within a 2-year exercise period and the Placing Warrants are conditional on passing of the shareholder resolutions at a forthcoming General Meeting. The net proceeds of the Placing will support the planned listing of Keras' Australian gold assets on the Australian Securities Exchange ('ASX'), as previously announced on 21 March 2017, commence cobalt exploration in West Africa upon the award of the licence, initiate a review of the feasibility study for the Company's Nayega manganese project in Togo and provide ongoing working capital for the Company. Further details regarding the proposed listing of the Company's gold assets on the ASX, along with the Notice of the forthcoming General Meeting, will be announced in due course. As previously announced, the Company plans to settle additional outstanding liabilities to certain Directors and members of the management team via the issue of additional Ordinary Shares following the forthcoming General Meeting, assuming the passage of Resolutions to increase the Company's share authorities. The proposed conversion of the Directors liabilities into Ordinary Shares reconfirms the Board's support for the Company's growth strategy as Keras embarks on a transitional period with the listing of the Company's gold assets on the ASX. Further announcements will be made as appropriate. In addition, a total of £15,000 owed to professional advisers is being settled via the issue of 4,285,714 Ordinary Shares in the Company (the 'New Ordinary Shares') at a price of 0.35p per New Ordinary Share. Keras Managing Director Dave Reeves said, "Following the positive reaction received in Australia towards the proposed listing of our Australian gold assets on the ASX, as highlighted through Pharmanet Group Limited raising an initial A$620,000 through an oversubscribed placing, we are pleased to have received similar support from investors in the UK. This £530,000 Placing will support the continued progression of the ASX listing, which we believe offers a significant and highly strategic opportunity through which we can better realise the potential value of our Australian gold assets."
cpap man
24/4/2017
15:24
The bargepole just got even longer here...I cannot see any reason why anyone would want to buy shares in this company
defcon3
21/4/2017
18:01
Hopefully not long 'To-go' before we get that license:)
the count of monte_cristo
20/4/2017
16:53
Dave please use your OZ charm to get this sorted ASAP. "Alongside our Australian interests, we have an 85% interest in the Nayega Manganese Project in Togo and have recently submitted applications for five exploration licences in West Africa that cover previously discovered, highly sought after cobalt and nickel mineralisation. We are confident these projects offer further upside opportunity to our investors and look forward to keeping the market updated with developments relating to our African portfolio and finalising the acquisition with Pharmanet/Calidus in the near term." GLA, GD
greatfull dead
19/4/2017
08:59
cpap man, Thank you for posting that sizzler. ATB, GD
greatfull dead
19/4/2017
08:13
Keras Resources (KRS.L, 0.42p) – Speculative Buy Keras' spin off of its Australian gold assets is progressing well. It's acquirer, an Australian listed vehicle (which will be called Calidus Resources) has raised the A$620k it needs to get the RTO process started. The placing was oversubscribed. The next stage is a larger up to A$8m raise to fund a major drilling campaign and development programme at the Warrawoona Gold Project. Post RTO, and assuming an A$8m raise, Keras will own 31% of Calidus which increases (potentially to 60%) if certain milestones are achieved. Our view: It is good news that the RTO is going to plan and that the placing was oversubscribed. Keras' gold assets should attract the funding they need on ASX while Keras can focus on its African portfolio of projects which includes manganese in Togo and potentially a nickel and cobalt project in west Africa (licences under application). Bear in mind that two of Keras' board members will be on the board of Calidus including Dave Reeves who will be managing director, so very well positioned to advance Warrawoona and win the milestone share payments for Keras and its shareholders. We have a Speculative Buy recommendation on Keras Resources. Beaufort Securities acts as Corporate Broker to Keras Resources plc
cpap man
18/4/2017
11:01
Ed, Hopefully we will. May if possible sounds great to me. ATB, GD
greatfull dead
18/4/2017
09:37
GD, Hopefully we'll soon find out. In the mean time we're fast approaching Calidus action, Dave hoped to be drilling in May. Regards, Ed.
edgein
18/4/2017
09:31
Ed, As you posted before going for Cobalt is a very smart move. I am wondering which country Dave has the mining applications in. ATB, GD
greatfull dead
18/4/2017
09:20
GD, Good man, I'm expecting it'll be mid to high 90's in the vote. 60% of Calidus and fully funded with lots of upside on the assets and their cap in the near term. Dave is 100% sure that the current resource will increase according to recent interviews. Given how little of the strike has been drilled and the recent drilling by KRS its not surprising, high grades open to EOH etc. Regards, Ed.
edgein
18/4/2017
09:14
Ed, Thanks for that. I will vote yes of course. ATB, GD
greatfull dead
18/4/2017
09:08
GD, Yes apparently we shall get a vote as its part of our assets that are getting listed on the ASX. It'll likely be my nominee broker that puts in the vote on my behalf, they normally do. Probably the same for you. Regards, Ed.
edgein
18/4/2017
08:44
Ed, Do AIM investor's get to vote? ATB, GD
greatfull dead
18/4/2017
08:23
Good to see the pre-listing Calidus getting good interest from the ozzies to get them through to the main fundraising for the listing. It'll be interesting what Dave will do on Klond with that cash mountain when it arrives. Also Cobalt is an interesting addition to the Mn asset when it finally arrives. Regards, Ed.
edgein
18/4/2017
07:30
Keras Resources plc / Index: AIM / Epic: KRS / Sector: Mining 18 April 2017 Keras Resources plc ("Keras" or "the Company") Oversubscribed Placing Raises A$620,000 to Support ASX Listing Keras Resources plc is pleased to announce that Pharmanet Group Limited ("Pharmanet") (ASX: PNO), the ASX listed company which the Company will reverse its wholly owned gold subsidiary, Keras (Gold) Australia Pty Ltd ("Keras Australia") into, has successfully raised A$620,000 (before expenses) from sophisticated investors in Australia (the "Placing"). The Proceeds of the Placing will support the planned listing of Keras' Australian gold assets on the Australian Securities Exchange ("ASX"), as previously announced on 21 March 2017. It is anticipated that Pharmanet, which is currently suspended from trading subject to completion of the proposed acquisition, will relist on the ASX as Calidus Resources Limited in Q2 2017. Keras Managing Director Dave Reeves said, "We made the strategic decision to list our Australian subsidiary on the ASX having identified significant interest from investors in-country looking to gain exposure to our highly prospective Australian gold assets. We are delighted to report that initial interest has proven to be extremely strong, with this placement comfortably raising the A$620,000 that was sought and being heavily oversubscribed. This gives us good indications for the support that can be expected for the larger capital raising to be undertaken as part of the proposed ASX listing. Crucially, the funds from the main listing will be used to support the rapid advancement of the gold assets, including a major drilling and exploration programme, and Scoping Studies at the Warrawoona Gold Project. The funds from the larger capital raise will also repay Keras' Acquisition Finance Facility, significantly strengthening our balance sheet." "Following the completion of the listing, Keras will be the major shareholder with commensurate board representation. This ensures we maintain significant strategic exposure to the assets, which will then be well funded to take the project forward whilst strengthening our balance sheet. Furthermore, with our Australian gold assets in a standalone listed entity, we believe Pharmanet/Calidus will have the requisite structure, resources and funding access to rapidly advance these assets to the benefit of all the Company's shareholders." "Alongside our Australian interests, we have an 85% interest in the Nayega Manganese Project in Togo and have recently submitted applications for five exploration licences in West Africa that cover previously discovered, highly sought after cobalt and nickel mineralisation. We are confident these projects offer further upside opportunity to our investors and look forward to keeping the market updated with developments relating to our African portfolio and finalising the acquisition with Pharmanet/Calidus in the near term."
cpap man
18/4/2017
07:17
RNS : Placing oversubscribedToday 07:11We are delighted to report that initial interest has proven to be extremely strong, with this placement comfortably raising the A$620,000 that was sought and being heavily oversubscribed. This gives us good indications for the support that can be expected for the larger capital raising to be undertaken as part of the proposed ASX listing. Crucially, the funds from the main listing will be used to support the rapid advancement of the gold assets, including a major drilling and exploration programme, and Scoping Studies at the Warrawoona Gold Project. The funds from the larger capital raise will also repay Keras' Acquisition Finance Facility, significantly strengthening our balance sheet."
temmujin
Chat Pages: 54  53  52  51  50  49  48  47  46  45  44  43  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20170428 00:37:49